SC
MRK icon

Scotia Capital’s Merck MRK Stock Holding History

Scotia Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-102,704
Closed -$5.17M – 799
2015
Q4 		$5.17M Buy
102,704
+29,344
+40% +$1.48M 0.12% 143
2015
Q3 		$3.46M Sell
73,360
-137,183
-65% -$7.29M 0.08% 182
2015
Q2 		$11.4M Buy
+210,543
New +$11.8M 0.23% 82

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Scotia Capital's MRK Position: Q2 2026 in Review

Scotia Capital reduced its Merck (MRK) stake by 8.3% in Q2 2026, selling an estimated $1.96M and leaving 185,895 shares worth $23.9M. The position accounts for 0.09% of the portfolio, ranked #131.

Scotia Capital first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $46.8M in Q4 2022. 3,834 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Scotia Capital held 185,895 shares of Merck worth $23.9M as of Q2 2026.
  • Scotia Capital sold 16,772 Merck shares in Q2 2026, an estimated $1.96M.
  • Merck made up 0.09% of Scotia Capital's portfolio in Q2 2026, its #131 holding.
  • Scotia Capital first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Scotia Capital's Merck position peaked at $46.8M in Q4 2022.
  • 3,834 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Scotia Capital's 13F filing for Q2 2026, filed 11 Aug 2026.